During the past decade, Inova Schar Cancer Institute Infusion Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inova Schar Cancer Institute Infusion Pharmacy" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Inova Schar Cancer Institute Infusion Pharmacy" are "Urothelial Cancer" (1 trials) and "mCRPC" (1 trials). Many other conditions were trialed in "Inova Schar Cancer Institute Infusion Pharmacy" in a lesser frequency.

Most popular intervention types in "Inova Schar Cancer Institute Infusion Pharmacy" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Best Supportive Care" (1 trials), "Following the planned interim analysis for this study: Avelumab" (1 trials), "Placebo with enzalutamide" (1 trials) and "Talazoparib with enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inova Schar Cancer Institute Infusion Pharmacy" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Inova Schar Cancer Institute Infusion Pharmacy". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Inova Schar Cancer Institute Infusion Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Inova Schar Cancer Institute Infusion Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".